Tissue oxygen partial pressure (PtO2) in animal models of obstructive sleep apnea and of hypoxia/reoxygenation

I. Almendros, R. Farré, M. Torres, D. Navajas, M. R. Bonsignore, J. M. Montserrat (Bunyola, , Barcelona, Spain; Palermo, Italy)

Source: Annual Congress 2010 - Sleep apnoea: insights from animal models and diagnostic tools
Session: Sleep apnoea: insights from animal models and diagnostic tools
Session type: Thematic Poster Session
Number: 4398
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Almendros, R. Farré, M. Torres, D. Navajas, M. R. Bonsignore, J. M. Montserrat (Bunyola, , Barcelona, Spain; Palermo, Italy). Tissue oxygen partial pressure (PtO2) in animal models of obstructive sleep apnea and of hypoxia/reoxygenation. Eur Respir J 2010; 36: Suppl. 54, 4398

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Positional obstructive sleep apnea (OSA) and automatic positive airway pressure (APAP) therapy
Source: Annual Congress 2012 - Technology, screening and questionnaires in OSA
Year: 2012


Catecholamines and obstructive sleep apnea (OSA) severity: response to positive airway pressure (PAP) therapy
Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea
Year: 2009


Importance of controlled blood pressure values in a population with obstructive sleep apnea syndrome (OSA) and arterial hypertension (HT)
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011


Early changes in blood pressure, vascular and heart function in obstructive sleep apnoea (OSA). Impact of treatment
Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment
Year: 2007

Effect of automatic positive airway pressure (APAP) therapy on blood pressure (BP) in patients with obstructive sleep apnea (OSA) and hypertension
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008


Influence of nasal obstruction (NO) on obstructive sleep apnea (OSA) severity and continuous positive airway pressure (CPAP) adaptation problems
Source: Annual Congress 2010 - The upper airway and oral appliances
Year: 2010

Retrospective analysis of oxygen therapy in persistent nocturnal hypoxia despite CPAP in obstructive sleep apnoea syndrome (OSAS)
Source: International Congress 2014 – Sleep disordered breathing 2
Year: 2014


Prediction of effective continuous positive airway pressure (CPAP) in obstructive sleep apnea syndrome (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 111s
Year: 2005

Signalling pathways in intermittent hypoxia and in obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment
Year: 2007


Effects of continuous nocturnal high oxygen concentrations in obstructive sleep apnea patients
Source: Annual Congress 2005 - Control of breathing
Year: 2005


Effects of continuous positive airway pressure on arterial stiffness and oxidative stress in patients with obstructive sleep apnoea
Source: International Congress 2016 – New insights into noninvasive ventilation: between the dream and reality
Year: 2016


Baroreflex control of heart rate during sleep in severe obstructive sleep apnoea: effects of acute CPAP
Source: Eur Respir J 2006; 27: 128-135
Year: 2006



Effects of treatments with nCPAP on cerebral blood flow velocity in patients with obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea
Year: 2009


Predictors of hypercapnia in obstructive sleep apnoea (OSA)
Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control
Year: 2010

Influence of adaptive servoventilation (ASV) on BNP in patients with Cheyne-Stokes respiration and central sleep apnea (CSR-CSA), with and without obstructive sleep apnea
Source: Annual Congress 2008 - Outcome of adaptive servo ventilation in sleep apnoea
Year: 2008


Blood pressure responsiveness to obstructive events during sleep after chronic CPAP
Source: Eur Respir J 2003; 21: 509-514
Year: 2003



Effects of reduced lung volumes and age on oxyhemoglobin nocturnal desaturation in obstructive sleep apnea patients before and after CPAP treatment
Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects II
Year: 2011

Utility of awake oxygen saturation to identify obstructive sleep apnoea
Source: International Congress 2019 – Diagnostic issues in obstructive sleep apnoea
Year: 2019


Peculiarities of nocturnal oxygen saturation in obstructive sleep apnoea
Source: Eur Respir J 2004; 24: Suppl. 48, 119s
Year: 2004

Prevalence and determinants of residual excessive daytime sleepiness (RES) in patients treated with continuous positive airway pressure (CPAP) for obstructive sleep apnea (OSA).
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020